Omnicell earnings were $2.1M for the trailing 12 months ending Dec 31, 2025, with -85.2% growth year over year. The latest OMCL earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$2.0M, down 137.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OMCL reported annual earnings of $2.1M, with -83.6% growth.
OMCL past earnings growth
How has OMCL's earnings growth performed historically?
On OMCL's earnings call on Invalid Date, Omnicell (NASDAQ: OMCL) reported Q4 2025 earnings per share (EPS) of -$0.05, up 114.71% year over year. Total OMCL earnings for the quarter were -$2.03 million. In the same quarter last year, Omnicell's earnings per share (EPS) was $0.34.
As of the last Omnicell earnings report, Omnicell is currently profitable. Omnicell's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $2.05 million, a 83.62% decrease year over year.
What was OMCL's earnings growth in the past year?
As of Omnicell's earnings date in Invalid Date, Omnicell's earnings has grown -85.19% year over year. This is 120.9 percentage points lower than the US Health Information Services industry earnings growth rate of 35.71%. OMCL earnings in the past year totalled $2.05 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.